AGA
TBIO

Altrinsic Global Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Altrinsic Global Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-30,000
Closed -$299K – 91
2020
Q1 		$299K Hold
30,000
– – 0.02% 77
2019
Q4 		$244K Buy
+30,000
New +$277K 0.01% 74

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Altrinsic Global Advisors's TBIO Position: Q2 2020 in Review

Altrinsic Global Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2020, closing a stake of 30,000 shares — an estimated $299K sold.

Altrinsic Global Advisors first reported a position in TBIO in Q4 2019 and held it in 2 quarters. The position peaked at $299K in Q1 2020. 133 funds tracked by Wall St. Rank hold TBIO as of Q2 2020.

  • Altrinsic Global Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Altrinsic Global Advisors sold 30,000 Translate Bio, Inc. Common Stock shares in Q2 2020, an estimated $299K.
  • Altrinsic Global Advisors first reported a position in Translate Bio, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Altrinsic Global Advisors's Translate Bio, Inc. Common Stock position peaked at $299K in Q1 2020.
  • 133 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2020.

Based on Altrinsic Global Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.